Related Experiment Videos
A HLA class I cis-regulatory element whose activity can be modulated by hormones
International Journal of Cancer
|December 1, 1994
Summary
Scientists discovered a novel DNA element that suppresses major histocompatibility complex (MHC) class I gene expression in breast cancer cells. This negative regulatory element (NRE) is modulated by hormones, offering new insights into cancer gene regulation.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Immunogenetics
Background:
- Major histocompatibility complex (MHC) class I gene expression is often down-regulated in human breast carcinoma.
- Understanding the transcriptional regulation of these genes is crucial for cancer research.
Purpose of the Study:
- To identify DNA-binding regulatory elements controlling class I MHC gene expression in breast cancer.
- To elucidate the mechanism of MHC class I gene down-regulation.
Main Methods:
- Band-shift assays were used to identify DNA sequences from the 5'-flanking region of HLA class I genes.
- Functional assays were performed to assess the inhibitory effects of the identified element on gene expression.
Main Results:
- A 9 base pair (bp) negative cis-regulatory element (NRE), GTCATGGCG, was identified within exon I of the HLA class I gene.
- This NRE potently inhibited heterologous gene promoters and HLA enhancer elements, functioning in both orientations.
- The NRE suppressed dexamethasone-mediated activation but not estrogen-mediated activation in MCF-7 cells.
Conclusions:
- The identified NRE plays a significant role in the hormonal down-regulation of HLA class I gene expression in breast cancer cells.
- Novel interactions between negative regulatory elements and hormone trans-activators suggest a versatile transcriptional control mechanism.